Clinical trials
Enrolling by invitation Attention Deficit Disorder with Hyperactivity trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ariel University | 1 |
| Boston Children's Hospital | 1 |
| Erasmus Medical Center | 1 |
| I-Ching Chou | 1 |
| IRCCS Centro Neurolesi Bonino Pulejo | 1 |
| King's College London | 1 |
| Medipol University | 1 |
| Neurolab Plus | 1 |
| Solli Distriktspsykiatriske Senter | 1 |
| Spanish National Research Council | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 11 |
| Autism Spectrum Disorder | 1 |
| COVID-19 | 1 |
| Cognition Disorders | 1 |
| Cognitive Dysfunction | 1 |
| Memory Disorders | 1 |
| Neurodevelopmental Disorders | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.